Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M16,002Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M344EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)23.1Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book3.810-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.5PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M100,000,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XLV

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

XLV is held by these investors:



XLV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rapps, MichaelDirector, Director or Senior Officer of 10% Securi 2017-01-16Buy1,200$9.48694.3view
Gridley, Anthony RonaldSenior Officer 2017-01-16Sell1,800$16.94344.51view
Dinwoodie, Tyler Wayne PaulSenior Officer 2017-01-16Buy4,000$0.1744194.12view
Brown, Mark ThomasDirector 2017-01-16Sell29,300$1.365436.76view
Bebek, IvanDirector 2017-01-16Buy8,990$3.382127.81view
smith, laurie james10% Security Holder, Director, Senior Officer 2017-01-16Buy7,500$0.4118265.85view
MEHR, JEFFREYSenior Officer 2017-01-13Sell50,000$27.91169.8view
Squibb, Geoffrey WayneDirector 2017-01-13Buy267$6.271100.96view
Smith, DavidSenior Officer 2017-01-13Sell15,000$60.3824.71view
Rowlands, William BruceDirector, Senior Officer 2017-01-13Buy20,000$0.1550100view

Quarterly/Annual Reports about XLV:

    News about XLV:

    Articles On GuruFocus.com
    S&P 500 Sector ETFs: A Look Under the Hood, Part 3 Mar 11 2015 
    Build a “Whatever Happens” Portfolio – Now! Aug 15 2014 
    Are Earnings Important? These Days, Revenues Count for More! Mar 17 2014 

    More From Other Websites
    Mixed bag for biotech earnings Apr 27 2017
    American health care is so messed up that a whole industry has been created to help navigate it Apr 27 2017
    What Analysts Recommend for Centene in 2017 Apr 27 2017
    Here's Why NeoGenomics, Inc. Is Dropping Today Apr 26 2017
    S&P 500 ETFs Eye Record Highs As Earnings Fuel Health Sector's Rise Apr 26 2017
    BD to Acquire C.R. Bard: Deal Highlights and Market Reaction Apr 26 2017
    How ZBH Stock Has Performed Recently Apr 26 2017
    What Analysts Recommend for Zimmer Biomet Apr 25 2017
    Analyst Recommendations for Quest Diagnostics in 2017 Apr 24 2017
    Understanding JNJ’s Stock Performance after the 1Q17 Results Apr 24 2017
    Eli Lilly’s 1Q17 Estimates for Elanco Apr 24 2017
    UnitedHealth Group Posted Robust Revenue Growth in 1Q17 Apr 24 2017
    A Roadmap To How An ACA Repeal Bill Could Hit Trump's Desk By Memorial Day Apr 22 2017
    Why the Bulls Appear to Be Out of Breath in 2Q17 Apr 19 2017
    Lackluster J&J Q1 Pushes Healthcare ETFs Down Apr 19 2017
    Democrats, White House And Health Insurers In Mexican Standoff As Govt. Shutdown Deadline Looms Apr 18 2017
    5 ETFs to Buy If You Love Johnson & Johnson's First-Quarter Earnings Apr 17 2017
    Health ETFs Wobble As FDA Spurns Arthritis Drug In Blow To Eli Lilly Apr 17 2017
    Here Are the Best Vanguard Funds To Buy (They're Not the Ones You Think) Apr 14 2017
    What to Expect from Johnson & Johnson’s 1Q17 Earnings Apr 13 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)